Sharechat Logo

Oceania Healthcare Limited (NZX: OCA) Delivers Improved Performance Despite COVID-19

Monday 29th November 2021

Text too small?

Oceania today announced unaudited proforma Underlying Earnings before interest, tax, depreciation and amortisation (EBITDA) of $36.5m for the six month period ended 30 September 2021, a 19.7%, ($6.0m) increase on the six month period ended 30 September 2020.

Oceania CEO Brent Pattison advised that “Oceania has continued to provide a safe, vibrant and well connected community for our residents despite the extended Governmental restrictions and costs associated with COVID-19. The business has responded well through high levels of vaccination, regular communications with staff, residents and their families, as well as a significant investment in surveillance, including declarations, online bookings and saliva testing.”

Oceania has been working with Government officials and Ministry of Health representatives with regard to health policy. Oceania has also taken an industry leadership position in calling for our Auckland residents to be allowed to reconnect with their loved ones safely. Oceania remains well-prepared to manage any infections that occur at its sites, with industry-leading infection control policies and a highly experienced clinical team.

Oceania Chair Liz Coutts noted “We were delighted to have welcomed Rob Hamilton and Peter Dufaur to the Board as independent Directors during September 2021. They bring an extensive range of skills and we are looking forward to them making a significant contribution to the future performance and growth of Oceania.”

Mrs Coutts advises the Board declared an interim dividend of 2.1 cents per share (unimputed) (30 November 2020: 1.3 cents). The record date for the dividend is 6 December 2021 and the payment date is 20 December 2021. The Dividend Reinvestment Plan will apply to the dividend payable on 20 December 2021 at a discount of 2.5% to the volume weighted average price of shares sold on the NZX Main Board over the period of the five trading days starting on 3 December 2021.

Please see the links below for details

Media Release

Interim Report

Results Presentation

Results Announcement

Distribution Notice

Source: Oceania Healthcare Limited

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

ArborGen Holdings Limited (NZX: ARB) Updates Market on FY22 Guidance
My Food Bag Group Limited (NZX: MFB) Q3 FY22 Trading Update
ikeGPS Group Limited (NZX: IKE) signs $0.9m deal with tier-1 electric utility
Tower Limited (NZX: TWR) Update on Tonga Volcanic Eruption and Tsunami Event
21st January 2022 Morning Report
Trade Window Holdings Limited (NZX: TWL) TradeWindow and Mastercard teams up
Genesis Energy Limited (NZX: GNE) FY22 Q2 Performance Report
Seeka Limited (NZX: SEK) Seeka announces dividend of 13 cents per share
20th January 2022 Morning Report
Z Energy Limited (NZX: ZEL) Q3FY33 Operating Data